TherapeuticsMD (TXMD) Financials: Revenue & Earnings
$20.72M
Market Cap
—
P/E
—
Forward P/E
—
Score
TXMD price $1.79 +0.01 +0.56%
TXMD fair value $4.80. Price $1.79. Price is 63% below fair value.
Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 699.23K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 11.57M. Net debt -1.39M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-17 | — | -6.12 | — | 19.77M |
| 2026-08-11 | 0.01 | -6.12 | 869.00K | 19.77M |
| 2026-05-12 | 0.01 | -6.12 | 724.00K | 19.77M |
| 2026-03-30 | -0.05 | 0.04 | 893.00K | 2.30M |
| 2025-11-12 | 0.01 | — | 784.00K | — |
| 2025-08-12 | 0.05 | — | 952.00K | — |
| 2025-05-13 | -0.06 | — | 393.00K | — |
| 2025-03-27 | 0.02 | 0.04 | 667.00K | 2.30M |
| 2024-11-12 | -0.05 | 0.04 | 547.00K | 2.30M |
| 2024-08-12 | -0.09 | 0.03 | 234.00K | 500.00K |
| 2024-05-10 | -0.07 | 0.03 | 313.00K | 500.00K |
| 2024-03-29 | -0.08 | -0.13 | 502.00K | 500.00K |
| 2023-11-14 | -0.13 | -0.15 | -53.00K | 500.00K |
| 2023-08-14 | -0.24 | -0.07 | 437.00K | 500.00K |
| 2023-05-15 | -0.24 | 0.06 | 416.00K | 1.70M |
| 2023-03-27 | -3.55 | -1.11 | 1.15M | 23.80M |
| 2022-11-14 | -3.13 | -2.04 | 20.92M | 26.80M |
| 2022-08-15 | 12.39 | -3.04 | 28.50M | 23.20M |
| 2022-05-16 | -4.72 | -3.50 | 19.33M | 17.95M |
| 2022-03-10 | -4.50 | -3.00 | 18.68M | 29.39M |
| 2021-11-11 | -5.50 | -5.00 | 25.41M | 25.87M |
| 2021-08-04 | -5.50 | -5.50 | 23.00M | 23.00M |
| 2021-05-06 | -5.50 | -5.00 | 19.87M | 21.52M |
| 2021-03-02 | -7.50 | -5.00 | 22.58M | — |
| 2020-11-09 | -5.00 | -7.00 | 19.34M | 22.11M |
| 2020-08-06 | -8.50 | -7.50 | 10.70M | 9.57M |
| 2020-05-06 | -10.50 | -9.50 | 12.25M | 11.08M |
| 2020-02-20 | -9.50 | -10.00 | 15.90M | 15.90M |
| 2019-11-06 | -6.50 | -9.50 | 23.72M | 34.67M |
| 2019-08-06 | -9.50 | -9.00 | 6.08M | 4.49M |
| 2019-05-06 | -8.00 | -8.50 | 3.95M | 4.19M |
| 2019-02-21 | -8.50 | -8.50 | 5.09M | 5.09M |
| 2018-11-07 | -8.00 | -11.00 | 3.47M | 4.56M |
| 2018-07-30 | -7.50 | -6.00 | 3.76M | 3.01M |
| 2018-05-03 | -5.50 | -5.00 | 3.77M | 3.43M |
| 2018-02-20 | -5.00 | -4.50 | 4.12M | 3.30M |
| 2017-11-06 | -3.50 | -4.50 | 4.42M | 6.95M |
| 2017-08-03 | -5.00 | -5.00 | 4.25M | 4.67M |
| 2017-05-02 | -5.50 | -5.50 | 3.99M | 3.99M |
| 2017-02-23 | -6.00 | -6.00 | 4.49M | 4.49M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2025-12-23 | Thompson Tommy G | Buy | 8.40K | $1.67 | 14.03K |
| 2025-11-03 | Thompson Tommy G | Buy | 8.50K | — | — |
| 2025-11-03 | Naughton Gail K | Buy | 8.50K | — | — |
| 2025-11-03 | Collins Cooper C. | Buy | 8.50K | — | — |
| 2025-11-03 | Walker Marlan D | Buy | 67.49K | $1.15 | 77.62K |
| 2025-04-14 | Thompson Tommy G | Buy | 325 | $1.00 | 326 |
| 2025-04-14 | Walker Marlan D | Buy | 490 | $1.00 | 489 |
| 2025-04-10 | Walker Marlan D | Buy | 1.17K | $0.86 | 1.00K |
| 2025-04-09 | Walker Marlan D | Buy | 1.14K | $0.87 | 994 |
| 2025-02-18 | Collins Cooper C. | Buy | 8.50K | — | — |
| 2025-02-18 | Collins Cooper C. | Sell | 8.50K | — | — |
| 2025-02-18 | Naughton Gail K | Buy | 8.50K | — | — |
| 2025-02-18 | Naughton Gail K | Sell | 8.50K | — | — |
| 2025-02-18 | Thompson Tommy G | Buy | 8.50K | — | — |
| 2025-02-18 | Thompson Tommy G | Sell | 8.50K | — | — |
| 2025-02-18 | Walker Marlan D | Buy | 1.73K | — | — |
| 2025-02-18 | Walker Marlan D | Buy | 770 | — | — |
| 2025-02-18 | Walker Marlan D | Buy | 2.31K | — | — |
| 2025-02-18 | Walker Marlan D | Buy | 3.47K | — | — |
| 2025-02-18 | Walker Marlan D | Sell | 1.73K | — | — |
| 2025-02-18 | Walker Marlan D | Sell | 770 | — | — |
| 2025-02-18 | Walker Marlan D | Sell | 3.47K | — | — |
| 2024-08-22 | Collins Cooper C. | Buy | 4.09K | $1.73 | 7.10K |
| 2024-08-21 | Collins Cooper C. | Buy | 1.20K | $1.70 | 2.04K |
| 2023-12-07 | Walker Marlan D | Sell | 4.55K | $2.24 | 10.19K |
| 2023-12-06 | Walker Marlan D | Sell | 14.50K | $2.31 | 33.50K |
| 2023-12-05 | Walker Marlan D | Buy | 70.00K | — | — |
| 2023-12-05 | Walker Marlan D | Sell | 70.00K | — | — |
| 2023-11-15 | Rubric Capital Management LP | Buy | 877.19K | $2.28 | 2.00M |
| 2023-08-17 | ZIEGLER JOSEPH | Buy | 7.50K | — | — |
| 2023-08-17 | ZIEGLER JOSEPH | Other | 0 | — | — |
| 2023-07-17 | Thompson Tommy G | Buy | 8.50K | — | — |
| 2023-07-17 | Naughton Gail K | Buy | 8.50K | — | — |
| 2023-07-17 | Collins Cooper C. | Buy | 8.50K | — | — |
| 2023-06-28 | Rubric Capital Management LP | Buy | 312.52K | $3.68 | 1.15M |
| 2023-04-26 | Walker Marlan D | Buy | 1.01K | — | — |
| 2023-04-26 | Walker Marlan D | Buy | 1.73K | — | — |
| 2023-04-26 | Walker Marlan D | Sell | 692 | $3.64 | 2.52K |
| 2023-04-26 | Walker Marlan D | Sell | 1.73K | — | — |
| 2023-04-26 | Walker Marlan D | Sell | 1.01K | — | — |
| 2023-04-12 | Walker Marlan D | Buy | 1.73K | — | — |
| 2023-04-12 | Walker Marlan D | Sell | 1.17K | $3.65 | 4.28K |
| 2023-04-12 | Walker Marlan D | Buy | 1.73K | — | — |
| 2023-04-12 | Walker Marlan D | Buy | 1.01K | — | — |
| 2023-04-12 | Walker Marlan D | Buy | 3.03K | — | — |
| 2023-04-12 | Walker Marlan D | Sell | 1.73K | — | — |
| 2023-04-12 | Walker Marlan D | Sell | 1.73K | — | — |
| 2023-04-12 | Walker Marlan D | Sell | 1.01K | — | — |
| 2023-04-12 | Walker Marlan D | Sell | 3.03K | — | — |
| 2023-04-12 | Donegan Michael C | Buy | 50.00K | — | — |
| 2023-04-12 | Donegan Michael C | Sell | 50.00K | — | — |
| 2023-02-21 | Walker Marlan D | Buy | 70.00K | — | — |
| 2023-02-21 | Donegan Michael C | Buy | 50.00K | — | — |
| 2023-01-27 | Donegan Michael C | Sell | 49 | $5.09 | 249 |
| 2023-01-26 | Donegan Michael C | Buy | 1.14K | — | — |
| 2023-01-26 | Donegan Michael C | Buy | 2.40K | — | — |
| 2023-01-26 | Donegan Michael C | Sell | 1.65K | $5.08 | 8.37K |
| 2023-01-26 | Donegan Michael C | Buy | 2.40K | — | — |
| 2023-01-26 | Donegan Michael C | Sell | 1.14K | — | — |
| 2023-01-24 | Donegan Michael C | Sell | 7 | $5.31 | 37 |
| 2023-01-23 | Donegan Michael C | Buy | 2.40K | — | — |
| 2023-01-23 | Donegan Michael C | Sell | 1.30K | $5.34 | 6.95K |
| 2023-01-23 | Donegan Michael C | Buy | 519 | — | — |
| 2023-01-23 | Donegan Michael C | Buy | 1.07K | — | — |
| 2023-01-23 | Donegan Michael C | Buy | 380 | — | — |
| 2023-01-23 | Donegan Michael C | Sell | 2.40K | — | — |
| 2022-12-31 | Walker Marlan D | Other | 0 | — | — |
| 2022-12-30 | Rubric Capital Management LP | Sell | 29.00K | $1,333.00 | 38.66M |
| 2022-12-30 | Rubric Capital Management LP | Sell | 29.00K | $1,333.00 | 38.66M |
| 2022-12-09 | Rubric Capital Management LP | Buy | 14.82K | $6.09 | 90.28K |
| 2022-12-09 | Bernick Brian | Sell | 320 | $6.31 | 2.02K |
| 2022-12-08 | Walker Marlan D | Sell | 716 | — | — |
| 2022-12-08 | Rubric Capital Management LP | Buy | 300 | $5.83 | 1.75K |
| 2022-12-07 | Rubric Capital Management LP | Buy | 20.11K | $5.66 | 113.89K |
| 2022-12-07 | Naughton Gail K | Sell | 3.92K | $5.26 | 20.64K |
| 2022-12-06 | Bernick Brian | Sell | 3.17K | — | — |
| 2022-12-06 | Bernick Brian | Buy | 3.17K | — | — |
| 2022-12-06 | Bernick Brian | Sell | 935 | $4.92 | 4.60K |
| 2022-12-06 | Walker Marlan D | Buy | 388 | — | — |
| 2022-12-06 | Walker Marlan D | Buy | 1.16K | — | — |
| 2022-12-06 | Walker Marlan D | Sell | 1.05K | $4.95 | 5.18K |
| 2022-12-06 | Walker Marlan D | Buy | 1.01K | — | — |
| 2022-12-06 | Walker Marlan D | Sell | 1.16K | — | — |
| 2022-12-06 | Walker Marlan D | Sell | 1.01K | — | — |
| 2022-12-06 | Walker Marlan D | Sell | 388 | — | — |
| 2022-12-06 | Glickman Mark A | Sell | 1.73K | — | — |
| 2022-12-06 | Glickman Mark A | Buy | 1.73K | — | — |
| 2022-12-06 | Glickman Mark A | Sell | 440 | $4.92 | 2.17K |
| 2022-12-06 | Donegan Michael C | Buy | 262 | — | — |
| 2022-12-06 | Donegan Michael C | Buy | 534 | — | — |
| 2022-12-06 | Donegan Michael C | Buy | 380 | — | — |
| 2022-12-06 | Donegan Michael C | Sell | 910 | $4.78 | 4.35K |
| 2022-12-06 | Donegan Michael C | Buy | 2.30K | — | — |
| 2022-12-06 | Donegan Michael C | Sell | 534 | — | — |
| 2022-12-06 | Donegan Michael C | Sell | 262 | — | — |
| 2022-12-06 | Donegan Michael C | Sell | 380 | — | — |
| 2022-12-06 | Donegan Michael C | Sell | 2.30K | — | — |
| 2022-10-28 | Rubric Capital Management LP | Buy | 7.00K | $1,000.00 | 7.00M |
| 2022-09-30 | Rosen David Efraim | Buy | 7.00K | $1,000.00 | 7.00M |
| 2022-09-30 | Rubric Capital Management LP | Buy | 7.00K | $1,000.00 | 7.00M |
Latest filed quarter: Q2 2026.
Institutions holding: 47, holders -2 vs prior quarter. Ownership 31.68%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 1.19M | 0 | 0.00% | 2.63M |
| CLEARLINE CAPITAL LP | 635.22K | 0 | 0.00% | 1.40M |
| VANGUARD CAPITAL MANAGEMENT LLC | 353.70K | 0 | 0.00% | 781.67K |
| TEJARA CAPITAL LTD | 344.48K | -1.37K | -0.40% | 761.30K |
| ADAR1 CAPITAL MANAGEMENT, LLC | 342.45K | 133.24K | +63.69% | 756.81K |
| RENAISSANCE TECHNOLOGIES LLC | 146.60K | 399 | +0.27% | 323.98K |
| MORGAN STANLEY | 129.22K | 0 | 0.00% | 285.57K |
| BLACKROCK, INC. | 115.14K | 0 | 0.00% | 254.47K |
| GEODE CAPITAL MANAGEMENT, LLC | 105.85K | -3.97K | -3.61% | 233.99K |
| CITADEL ADVISORS LLC | 86.09K | 59.30K | +221.25% | 190.27K |
| VANGUARD FIDUCIARY TRUST CO | 63.83K | 0 | 0.00% | 141.07K |
| STATE STREET CORP | 30.10K | 0 | 0.00% | 66.52K |
| XTX TOPCO LTD | 21.25K | -6.24K | -22.71% | 46.95K |
| DIMENSIONAL FUND ADVISORS LP | 19.72K | 9.01K | +84.19% | 43.58K |
| NORTHERN TRUST CORP | 18.56K | 2.46K | +15.30% | 41.01K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 17.00K | 0 | 0.00% | 37.57K |
| OSAIC HOLDINGS, INC. | 15.20K | 15.04K | +9833.33% | 33.59K |
| HRT FINANCIAL LP | 14.73K | 14.73K | New | 32.00K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13.10K | 13.10K | New | 28.95K |
| JANE STREET GROUP, LLC | 12.50K | 200 | +1.63% | 27.62K |
| VANGUARD GLOBAL ADVISERS, LLC | 4.94K | 0 | 0.00% | 10.91K |
| UBS GROUP AG | 4.66K | 4.33K | +1307.85% | 10.30K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.58K | 73 | +4.84% | 3.50K |
| SBI SECURITIES CO., LTD. | 1.26K | 996 | +373.03% | 2.79K |
| SMARTLEAF ASSET MANAGEMENT LLC | 601 | 0 | 0.00% | 1.35K |
TherapeuticsMD, Inc. (TXMD) trades at $1.79, with a market cap of $20.72M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$20.72M
Market Cap
—
P/E
—
Forward P/E
—
Score